Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis

Vaccine

Volumn 23, Issue 28, 2005, Pages 3642-3648

  Khamesipour, Ali ^a   Dowlati, Yahya ^a   Asilian, Ali ^b   Hashemi Fesharki, Reza ^c   Javadi, Amir ^d   Noazin, Sassan ^e   Modabber, Farrokh ^e,f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c RAZI VACCINE AND SERUM RESEARCH INSTITUTE   (Iran)

^d QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNICEF   (United States)

^f NONE   (France)

Author keywords

Iran; Leishmania; Leishmanization; Live challenge; Vaccine

Indexed keywords

LEISHMANIA VACCINE; LIVE VACCINE; MEGLUMINE ANTIMONATE; PAROMOMYCIN;

ADULT; ANIMAL MODEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG SAFETY; FOLLOW UP; FREEZING; HEALING; HUMAN; HUMAN CELL; INOCULATION; LEISHMANIA MAJOR; LEISHMANIASIS; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SAMPLE SIZE;

ADULT; ANIMALS; HUMANS; IRAN; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; PROTOZOAN VACCINES; SKIN TESTS; VIRULENCE;

EID: 18844452635     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.02.015     Document Type: Article

References (35)

1. P. Desjeux Leishmaniasis. Public health aspects and control Clin Dermatol 14 5 1996 417 423
2. F.E.G. Cox Old World leishmaniasis F.E.G. Cox The Wellcome Trust illustrated history of tropical diseases 1996 The Wellcome Trust London 207 217
3. A. Nadim, E. Javadian, G. Tahvildar-Bidruni, and M. Ghorbani Effectiveness of leishmanization in the control of cutaneous leishmaniasis Bull Soc Pathol Exot Filiales 76 4 1983 377 383
4. F. Modabber Exp with vaccine against CL: of men and mice Parasitology 98 Suppl 1989 49 60
5. H.A. Senekji, and C.P. Beattie Artificial infection and immunization of man with cultures of L. tropica Trans R Soc Trop Med Hyg 34 1941 415 419
6. E.I. Marzinowsky, and A. Schurenkova Oriental sore and immunity against it Trans R Soc Trop Med Hyg 18 1924 67 69
7. C.L. Greenblatt The present and future of vaccination for cutaneous leishmaniasis A. Mizrahi I. Hertman M.A. Klingberg A. Kohn New developments with human and veterinary vaccine 1980 Alan R Liss Inc. New York 259 285
8. C.L. Greenblatt, D.T. Spira, B. Montillio, and H. Gerichner An improved protocol for the preparation of a frozen promastigote vaccine for cutaneous leishmaniasis J Biol Stand 8 1980 227 232
9. E. Witztum, C.L. Greenblatt, J. Kark, D.T. Spira, Z. Koufman, and D. Michaeli Development of a storable Leishmania tropica vaccine: field testing with frozen promastigotes Israel J Med Sci 15 1979 749 753
10. A. Nadim, and E. Javadian Leishmanization in Iran B. Walton P.M. Wijeyaretne F. Modabber Research on strategies for the control of leishmaniasis 1988 International Development Research Center Ottawa 336 369
11. V.P. Sergiev Control and prophylaxis of cutaneous leishmaniasis in the middle Asia republics of the former USSR Bull Soc Fran parasit 10 1992 183
12. I.M. Gafurov Experience in controlling and preventing zoonotic cutaneous leishmaniasis in Uzbekistan Med Parazitol (Mosk) 1 1999 58 59
13. Antunes CMF, W. Mayrink, P.A. Magalhaes, M.N. Melo, M. Dias, and S.M. Michalick Controlled field trials of a vaccine against New World cutaneous leishmaniasis Int J Epidemiol 15 1986 572 580
14. R. Hashemi-Fesharki, S. Ale-Agha, P. Ahourai, E. Djavadian, A. Taghavi, and A. Golabi Vaccine preparation and quality control of killed Leishmania major Arch Inst Razi 42/43 1992 39 50
15. E.A.G. Khalil, A.M. El Hassan, E.E. Zijlstra, M.M. Mukhtat, H.W. Ghalib, and B. Musa Autoclaved L. major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan Lancet 356 2000 1565 1569
16. I. Sharifi, A. Fekri, M. Aflatonian, A. Khamesipour, A. Nadim, and M.R.A. Mousavi Double-blind randomised controlled vaccine trial of a single dose of killed Leishmania major plus Bacillus of Calmette Guerin (BCG) against anthroponotic cutaneous leishmaniasis Bam, Iran Lancet 351 1998 1540 1543
17. R.X. Armijos, M.M. Weigel, H. Aviles, R. Maldonado, and J. Racines Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up J Infect Dis 177 5 1998 1352 1357
18. A.Z. Momeni, T. Jalayer, M. Emamjomeh, A. Khamesipour, F. Zicker, and R. Labaf Ghasemi A randomized, double blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran Vaccine 17 5 1999 466 472
19. R.T. Kenney, D.L. Sacks, J.P. Sypek, L. Vilela, A.A. Gam, and K. Evans-Davis Protective immunity using recombinant human IL-12 and alum as adjuvants in a primate model of cutaneous leishmaniasis J Immunol 163 8 1999 4481 4488
20. A. Misra, A. Dube, B. Srivastava, P. Sharma, J.K. Srivastava, and J.C. Katiyar Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG Vaccine 19 2001 3485 3492
21. I.N. Satti, H.Y. Osman, N.S. Daifalla, S.A. Younis, E.A. Khalil, and E.E. Zijlstra Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers Vaccine 19 15/16 2001 2100 2106
22. D. Sacks, and N. Boben-Trauth The immunology of susceptibility and resistance to L. major in mice Nature Rev Immunol 2 2002 845 854
23. Modabber F, Reed S, Campos-Neto A, New generation vaccines. In: Levine M, et al. (Eds.), Leishmaniasis Vaccines, 2004, in press.
24. C.O. Tacket, M.B. Cohen, S.S. Wasserman, G. Losonsky, S. Livio, and K. Kotloff Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination Infect Immun 67 1999 6341 6345
25. C.O. Tacket, K.L. Kotloff, G. Losonsky, J.P. Nataro, J. Michalski, and J.B. Kaper Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111 Am J Trop Med Hyg 56 5 1997 533 537
26. E. Djavadian, A. Nadim, G.H. Tahvildarie, and V. Assefi Epidemiology of cutaneous leishmaniasis in Iran B. Khorassan Bull Soc Path Exotique 69 1976 140 143
27. M.H. Alimohammadian, H. Hakimi, and M.A. Nikseresht The preparation and evaluation of reference leishmanin from Leishmania major for use in man for diagnostic and experimental purposes Med J Islamic Rep Iran 7 1993 23 28
28. J.E. Sokal Editorial: Measurement of delayed skin-test responses N Engl J Med 293 10 1975 501 502
29. M. Mahmoodi, A. Khamesipour, Y. Dowlati, S. Rafati, A.Z. Momeni, and M. Emamjomeh Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG Clin Exp Immunol 134 2 2003 303 308
30. A. Asilian, T. Jalayer, M. Nilforoushzadeh, R.L. Ghassemi, R. Peto, and W. Wayling Treatment of cutaneous leishmaniasis with Aminosidine (paromomycin) ointment: double blind, randomized and placebo controlled trial in Iran Bull World Health Organ 81 2003 353 359
31. Shazad B, Abbaszadeh B, Khamesipour A. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimonate for the treatment of cutaneous leishmaniasis caused by L. major, Eur J Dermotol 2005;15(2):1-3.
32. D.L. Sacks, and P.V. Perkins Identification of an infective stage of Leishmania promastigotes Science 30/223 4643 1984 1417 1419
33. Y. Dowlati, K. Bahar, S. Ehsasi, and B. Shidani Stepwise safety trial of a killed Leishmania vaccine in Iran Clin Dermatol 14 5 1996 496 502
34. K. Bahar, Y. Dowlati, B. Shidani, M.H. Alimohammadian, A. Khamesipour, and S. Ehsasi Comparative safety and immunogenicity trial of two killed Leishmania major with or without BCG in human volunteers Clin Dermatol 14 5 1996 489 495
35. M. Ouellette, and B. Papadopoulou Selective killing of Leishmania amastigotes expressing a thymidine kinase suicide gene Exp Parasitol 85 1997 35 42